| Year |
Citation |
Score |
| 2014 |
Marlatt MW, Bauer J, Aronica E, van Haastert ES, Hoozemans JJ, Joels M, Lucassen PJ. Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition. Neural Plasticity. 2014: 693851. PMID 25215243 DOI: 10.1155/2014/693851 |
0.54 |
|
| 2013 |
Marlatt MW, Potter MC, Bayer TA, van Praag H, Lucassen PJ. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease. Current Topics in Behavioral Neurosciences. 15: 313-40. PMID 23670818 DOI: 10.1007/7854_2012_237 |
0.333 |
|
| 2011 |
van Tijn P, Kamphuis W, Marlatt MW, Hol EM, Lucassen PJ. Presenilin mouse and zebrafish models for dementia: focus on neurogenesis. Progress in Neurobiology. 93: 149-64. PMID 21056616 DOI: 10.1016/J.Pneurobio.2010.10.008 |
0.434 |
|
| 2010 |
Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA, Lee HG, Perry G. Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease. International Journal of Biomedical Science : Ijbs. 6: 225-227. PMID 21765811 |
0.806 |
|
| 2010 |
Marlatt MW, Lucassen PJ. Neurogenesis and Alzheimer's disease: Biology and pathophysiology in mice and men. Current Alzheimer Research. 7: 113-25. PMID 19860727 DOI: 10.2174/156720510790691362 |
0.383 |
|
| 2010 |
Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Experimental Neurology. 221: 26-37. PMID 19751725 DOI: 10.1016/j.expneurol.2009.09.005 |
0.586 |
|
| 2009 |
Friedlich AL, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Lee HG, Casadesus G, Perry G, Smith MA. Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1. PMID 20948726 DOI: 10.3410/M1-54 |
0.785 |
|
| 2009 |
Marlatt MW, Hoozemans JJ, Veerhuis R, Lucassen PJ. Alzheimer’s disease and adult neurogenesis—Are endogenous stem cells part of the solution? Us Neurology. 5: 12-14. DOI: 10.17925/Usn.2009.05.01.12 |
0.33 |
|
| 2009 |
Lucassen PJ, Marlatt M, Bauer J, Wouda J, Hoozemans JJM. Coordinated evaluation of astrogliosis, microglial activation and proliferation in the Alzheimer hippocampus in relation to cognitive status and amyloid pathology Alzheimers & Dementia. 5: 312. DOI: 10.1016/J.Jalz.2009.04.487 |
0.329 |
|
| 2009 |
Marlatt MW, Moreira PI, Lee Hg, Casadesus G, Castellani RJ, Takeda A, Nunomura A, Zhu X, Perry G, Smith MA. Therapeutic opportunities in Alzheimer disease: Current concepts Frontiers in Medicinal Chemistry. 4: 767-788. |
0.704 |
|
| 2008 |
Marlatt MW, Lucassen PJ, Perry G, Smith MA, Zhu X. Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. Journal of Alzheimer's Disease : Jad. 15: 199-210. PMID 18953109 DOI: 10.3233/Jad-2008-15206 |
0.791 |
|
| 2008 |
Savage MJ, McCampbell AR, Wessner K, Na S, Marlatt M, Bickel D, Burno M, Jones K, Kuzmick-Graufelds V, Yeh S, Zhang R, White R, Seager M, Majercak J, Ray WJ. P1-016: Dietary induction of hyperhomocystemia and the impact on Alzheimer's disease-relevant markers Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.601 |
0.509 |
|
| 2006 |
McShea A, Marlatt MW, Lee HG, Tarkowsky SM, Smit M, Smith MA. The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information? Journal of Neuropathology and Experimental Neurology. 65: 1031-9. PMID 17086099 DOI: 10.1097/01.jnen.0000240471.04920.3c |
0.652 |
|
| 2005 |
Webber KM, Casadesus G, Marlatt MW, Perry G, Hamlin CR, Atwood CS, Bowen RL, Smith MA. Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Annals of the New York Academy of Sciences. 1052: 201-9. PMID 16024763 DOI: 10.1196/Annals.1347.020 |
0.745 |
|
| 2005 |
Webber KM, Raina AK, Marlatt MW, Zhu X, Prat MI, Morelli L, Casadesus G, Perry G, Smith MA. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mechanisms of Ageing and Development. 126: 1019-25. PMID 15936057 DOI: 10.1016/J.Mad.2005.03.024 |
0.788 |
|
| 2005 |
Marlatt MW, Webber KM, Moreira PI, Lee HG, Casadesus G, Honda K, Zhu X, Perry G, Smith MA. Therapeutic opportunities in Alzheimer disease: one for all or all for one? Current Medicinal Chemistry. 12: 1137-47. PMID 15892629 DOI: 10.2174/0929867053764644 |
0.797 |
|
| 2004 |
Zhu X, Webber KM, Casadesus G, Raina AK, Lee HG, Marlatt M, Hartzler A, Atwood CS, Perry G, Smith MA. Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities. Current Drug Targets. 5: 559-63. PMID 15270202 DOI: 10.2174/1389450043345317 |
0.765 |
|
| 2004 |
Lee HG, Zhu X, O'Neill MJ, Webber K, Casadesus G, Marlatt M, Raina AK, Perry G, Smith MA. The role of metabotropic glutamate receptors in Alzheimer's disease. Acta Neurobiologiae Experimentalis. 64: 89-98. PMID 15190683 |
0.75 |
|
| 2004 |
Marlatt M, Lee HG, Perry G, Smith MA, Zhu X. Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. Acta Neurobiologiae Experimentalis. 64: 81-7. PMID 15190682 |
0.779 |
|
| Show low-probability matches. |
